Arena Pharmaceuticals (ARNA) Trades Down Following Stock Offering
Tweet Send to a Friend
Up)
Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) is initially trading down 3 percent following the announcement of a stock offering after the close Tuesday.
The company didn't provide an amount but said the offering will be made through Jefferies & Company, Inc. and Piper Jaffray & Co.
Arena surged recently following FDA panel backing of its obesity drug Lorcaserin.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
The company didn't provide an amount but said the offering will be made through Jefferies & Company, Inc. and Piper Jaffray & Co.
Arena surged recently following FDA panel backing of its obesity drug Lorcaserin.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: Crash in American Electric Power (AEP) & NextEra Energy (NEE) Adds to Jitters
- Mannkind (MNKD) Continues Higher
- UPDATE: Cell Therapeutics (CTIC) on The Move
Create E-mail Alert Related Categories
Equity Offerings, Momentum Movers, Trader TalkRelated Entities
Piper Jaffray, Jefferies & Co
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
